Paid Clinical Trials Georgia
Discover 1,800 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyThe eMESH 1 Feasibility Study
Sponsor:
Kips Bay Medical, Inc.
Location:
Code:
NCT01676376
Conditions
Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Not accepted
Interventions
eSVS Mesh treated saphenous vein graft
Control saphenous vein graft
Von Willebrand FactorVon Willebrand Factor in Pregnancy (VIP) Study
Sponsor:
University of Washington
Location:
Code:
NCT04146376
Conditions
Von Willebrand Diseases
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Use of a postpartum diary and additional blood draws
VWF replacement therapy with Wilate
Tranexamic acid
Use of a postpartum diary and additional blood draws.
Lomustine with Temozolomide & RadiationTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Sponsor:
NRG Oncology
Location:
Code:
NCT05095376
Conditions
Glioblastoma
Gliosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Lomustine
Magnetic Resonance Imaging
Photon Beam Radiation Therapy
Questionnaire Administration
Temozolomide
AMT-162Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
Sponsor:
UniQure Biopharma B.V.
Location:
Code:
NCT06100276
Conditions
Amyotrophic Lateral Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AMT-162
Sacituzumab Tirutecan & PembrolizumabA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312176
Conditions
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Paclitaxel
Nab-paclitaxel
Capecitabine
Tilmanocept vs. Sulfur ColloidTilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy
Sponsor:
Memorial Health University Medical Center
Location:
Code:
NCT03199560
Conditions
Sentinel Lymph Node Biopsy
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tc 99m tilmanocept
Tc 99m filtered sulfur colloid
RavulizumabStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06291376
Conditions
Immunoglobulin A Nephropathy
IgAN
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ravulizumab
Placebo
Observational StudyProduct Surveillance Registry
Sponsor:
Medtronic
Location:
Code:
NCT01524276
Conditions
Cardiac Rhythm Disorders
Urological Disorders
Neurological Disorders
Cardiovascular Disorders
Digestive Disorders
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Proton vs. PhotonComparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT03801876
Conditions
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Esophagectomy
Intensity-Modulated Radiation Therapy
Paclitaxel
Proton Beam Radiation Therapy
VX-993Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Sponsor:
Vertex Pharmaceuticals Incorporated
Location:
Code:
NCT06619860
Conditions
Diabetic Peripheral Neuropathic Pain
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
VX-993
Pregabalin
Placebo (matched to pregabalin)
Placebo (matched to VX-993)